August 11, 2014
Newer medications that got the green light from the
US Food and Drug Administration had more than a one in four likelihood of receiving a black box warning or being withdrawn from the market within 25 years of their approval. That compares to one in five drugs in 1992, the year Congress passed legislation to allow the
FDA to collect pharmaceutical industry fees to speed drug approvals.
continue to read
here
No comments:
Post a Comment